Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Adaptec (ADPT) -- Ignore unavailable to you. Want to Upgrade?

To: Starowl who wrote (1169)	3/12/1998 10:03:00 PM
From: Jim Switz	Respond to of 5944

Starowl said: Adaptec's purchase of Symbios should boost gross revenue by at least 50%, but we have no data to estimate Symbios' profits and thus can only guess at the initial impact of the merger on Adaptec's bottom line. Therefore I say: As I recall from a posting here a couple of weeks back (I believe it was a Korean publication article), Symbios had revenues of about $620M in '97 and net earnings of $69M. If these are accounted for in a similar fashion to what we're accustomed to in the USA, both would be significant contributions to ADPT's numbers. I thought the percentage of net earnings seemed a little low (especially to ADPT), but I have no idea what the gross margins are in Symbios' product line. Has anyone seen a Symbios financial statement posted anywhere?